QA: ELI LILLY & Co in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000059478_2023_ELI_LILLY_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000059478, ELI LILLY & Co

  xvar xval
0 AssetsCurrent 18,034,500,000
1 IntangibleAssetsNetIncludingGoodwill 11,279,600,000
2 PropertyPlantAndEquipmentNet 10,144,000,000
3 remainder_Assets 10,031,700,000
4 LiabilitiesCurrent 17,138,200,000
5 LiabilitiesNoncurrent 21,576,200,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 6,629,800,000
8 SellingGeneralAndAdministrativeExpense 6,440,400,000
9 ResearchAndDevelopmentExpense 7,190,800,000
10 remainder_Expenses 2,035,600,000
11 remainder_Revenues 28,541,400,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 498,500,000
  yvar yval
0 Assets 49,489,800,000
1 Liabilities 38,714,400,000
2 Expenses 22,296,600,000
3 Revenues 28,541,400,000
4 StockholdersEquity 10,775,400,000
5 NetIncome 6,244,800,000
6 ComprehensiveNetIncome 6,494,050,000
7 BaseVar 69,770,350,000
8 EconomicCapitalRatio 0.567

Edgar->Model Mapping

Feature Distribution

Change over Time